These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 307014)

  • 21. Induction or suppression of B cell proliferation and differentiation by phytohemagglutinin or concanavalin A in mouse spleen cell cultures.
    Piguet PF; Dewey HK; Vassalli P
    J Immunol; 1976 Nov; 117(5 Pt.2):1817-23. PubMed ID: 1086865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonspecific activation of murine lymphocytes. VI. Mediation of synergistic interaction between T and B lymphocytes by a cell-associated, reciprocally acting lymphocyte proliferation helper.
    Goodman MG; Weigle WO
    J Exp Med; 1979 Mar; 149(3):644-57. PubMed ID: 311812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor T cell activation by human leukocyte interferon.
    Schnaper HW; Aune TM; Pierce CW
    J Immunol; 1983 Nov; 131(5):2301-6. PubMed ID: 6226738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro immunization. Effect of growth and differentiation factors on antigen-specific B cell activation and production of monoclonal antibodies to autologous antigens and weak immunogens.
    Borrebaeck CA; Möller SA
    J Immunol; 1986 May; 136(10):3710-5. PubMed ID: 3486221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyclonal activation of the murine immune system by an antibody to IgD. VII. Demonstration of the role of nonantigen-specific T help in in vivo B cell activation.
    Finkelman FD; Smith J; Villacreses N; Metcalf ES
    J Immunol; 1984 Aug; 133(2):550-5. PubMed ID: 6203966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo obtained antigen presented by germinal center B cells to T cells in vitro.
    Kosco MH; Szakal AK; Tew JG
    J Immunol; 1988 Jan; 140(2):354-60. PubMed ID: 3257234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.
    Dosch H-M ; Gelfand EW
    J Immunol; 1977 Jan; 118(1):302-8. PubMed ID: 401513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogenicity of Entamoeba histolytica extracts for murine lymphocytes.
    Diamantstein T; Trissl D; Klos M; Gold D; Hahn H
    Immunology; 1980 Oct; 41(2):347-52. PubMed ID: 6254869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of regulatory components from resident T lymphocytes in polyclonal B cell activation.
    Goodman MG; Weigle WO
    J Cell Biochem; 1982; 18(4):395-405. PubMed ID: 6211460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of the in vitro secondary antibody response. II. Antigen-induced murine splenic T cell proliferation.
    Walker SM; Morgan EL; Weigle WO
    J Immunol; 1981 Feb; 126(2):766-9. PubMed ID: 6969762
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanism of NK cell activation: relationship between Qa5+ NK cells and lymphocytes.
    Chun M; Fernandes G; Hoffmann MK
    J Immunol; 1981 Jan; 126(1):331-4. PubMed ID: 7451974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.
    Ryan JJ; Ahmed A; Kind PD; Thompson CB; Berning AK; Sell KW
    J Immunol; 1984 Aug; 133(2):606-15. PubMed ID: 6234352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative immunotoxicity evaluation of amphotericin B and ABELCET, an amphotericin B lipid complex (ABLC).
    Zhang Z; Lipman JM; Diener RM; Thomas P
    Int J Toxicol; 2006; 25(6):487-92. PubMed ID: 17132607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic activity of antigen receptors artificially incorporated onto B lymphocytes.
    Peacock JS; Londo TR; Roess DA; Barisas BG
    J Immunol; 1986 Sep; 137(6):1916-23. PubMed ID: 2427584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin-induced T lymphocyte proliferation.
    Vogel SN; Hilfiker ML; Caulfield MJ
    J Immunol; 1983 Apr; 130(4):1774-9. PubMed ID: 6601137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SA96: an immunopharmacological profile in vitro.
    Yamamoto I; Ohmori H; Okimura T
    Int J Tissue React; 1982; 4(1):1-8. PubMed ID: 7200957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-immunoglobulin stimulation of murine lymphocytes. VII. Identification of an age-dependent change in accessory cell function.
    Scribner DJ; Moorhead JW
    J Immunol; 1982 Mar; 128(3):1377-81. PubMed ID: 6976991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial restoration of the lipopolysaccharide-induced proliferative response in splenic B cells from C3H/HeJ mice.
    Kuus-Reichel K; Ulevitch RJ
    J Immunol; 1986 Jul; 137(2):472-7. PubMed ID: 3487572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.